DVT and related indications comprise the overwhelming majority of the US Lovenox market. ACS is a single-digit percentage—see the orange pie slice in #msg-28936334.
I think NVS/MNTA’s label will soon to be expanded to include ACS but, even if it isn’t, it barely matters to MNTA’s take.
Market Data 
Markets 
AI
